Company / Shares Outstanding
Intellia Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
102.0M
FY2025
5-year range
66.2M / 102.0M
FY2021-FY2025
Trend
+9.7%
vs FY2024
Sector context
#79 of 165
Health Care
What the data says
At 102029594.00, Intellia Therapeutics, Inc.'s shares outstanding ranks #87 of 165 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 22222000.00 in FY2016 to 102029594.00 in FY2025.
Based on SEC 10-K filings.
102029594.00 in FY2025 with a 5-year CAGR of +15.2%.
Increased from 87103007.00 to 102029594.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
#87 of 165 in Health CareTop 52% of 165This company 102.0M Sector average 170.3M
▼
-40.1% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 9.7% year-over-year.
- Ranks #79 out of 165 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 102.0M | +9.7% |
| FY2024 | 93.0M | +6.8% |
| FY2023 | 87.1M | +16.9% |
| FY2022 | 74.5M | +12.5% |
| FY2021 | 66.2M | +31.9% |
| FY2020 | 50.2M | +11.0% |
| FY2019 | 45.2M | +6.7% |
| FY2018 | 42.4M | +17.7% |
| FY2017 | 36.0M | +62.0% |
| FY2016 | 22.2M | +9044.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026